Results 71 to 80 of about 5,546 (214)

Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB. [PDF]

open access: yes, 2016
Repurposing has gained momentum globally and become an alternative avenue for drug discovery because of its better success rate, and reduced cost, time and issues related to safety than the conventional drug discovery process.
Brindha, Sridharan   +4 more
core   +1 more source

Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study. [PDF]

open access: yesPLoS ONE, 2016
OBJECTIVE:The aim of this study was to assess the efficacy (response rate centered on 80%) of a somatostatin analog with high affinity for 4 somatostatin receptors in reducing the postoperative incidence of symptomatic lymphocele formation following ...
Elisabeth Chéreau   +8 more
doaj   +1 more source

Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing's disease [PDF]

open access: yes, 2017
Pituitary surgery represents the first-line treatment for most patients with Cushing\u2019s disease (CD). In the case of surgery failure, additional treatment options are required.
Ciresi, A.   +4 more
core   +1 more source

Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review [PDF]

open access: yes, 2018
Pancreatic cancer has a dismal prognosis particularly in patients presenting with unresectable tumors. We performed a bibliometric analysis of clinical trials for pancreatic cancer conducted between 2014-2016 focusing on patients that presented with ...
Biankin, Andrew V.   +3 more
core   +1 more source

Hypersomatotropism and Hypercortisolism Caused by a Plurihormonal Pituitary Adenoma in a Dog

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT A 12‐year‐old, male Labrador Retriever was presented because of polyuria, polydipsia, polyphagia, joint pain, and physical features consistent with acromegaly. Circulating insulin‐like growth factor‐1 (IGF‐1) concentration was increased (> 1000 ng/mL; reference interval [RI], 42–449), suggestive of hypersomatotropism.
Elber A. Soler Arias   +3 more
wiley   +1 more source

High variability in baseline urinary free cortisol values in patients with Cushing's disease [PDF]

open access: yes, 2013
Objective Twenty-four-hour urinary free cortisol (UFC) sampling is commonly used to evaluate Cushing's syndrome. Because there are few data on UFC variability in patients with active Cushing's disease, we analysed baseline UFC in a large patient ...
Biller, B. M. K.   +9 more
core   +3 more sources

Pasireotide after Surgery for Persistent Cushing’s Disease [PDF]

open access: yesModern Medicine, 2019
Introduction: Cushing’s disease (CD) is characterized by multiple complications, particularly due to the condition itself, but also as a result of curative treatment. Nowadays, transsphenoidal surgery is considered the first-line therapy.
Dan Nicolae PADURARU   +11 more
doaj   +1 more source

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue S2, Page 20-34, April 2025.
ABSTRACT Background The prevalence of obesity and related co‐morbidities has reached epidemic proportions. Effective evidence‐based treatment approaches are therefore important. Lifestyle intervention remains the mainstay of the treatment strategy to manage obesity.
Iskandar Idris, Oluwaseun Anyiam
wiley   +1 more source

Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study [PDF]

open access: yes, 2018
A randomized, double-blind, placebo-controlled, cross-over, dose-escalating, single-center study was conducted to evaluate the safety, tolerability, and pharmacokinetic (PK) profile of multiple once-daily (qd) subcutaneous (sc) doses of pasireotide in ...
Beglinger, Christoph   +6 more
core  

Mid-gut ACTH-secreting neuroendocrine tumor unmasked with (18)F-dihydroxyphenylalanine-positron emission tomography. [PDF]

open access: yes, 2015
Ectopic ACTH Cushing's syndrome (EAS) is often caused by neuroendocrine tumors (NETs) of lungs, pancreas, thymus, and other less frequent locations. Localizing the source of ACTH can be challenging.
Boubaker, A.   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy